How T cells influence tau-related brain damage in Alzheimer's and similar conditions
Role of T cells in tau-mediated neurodegeneration
Researchers are looking at whether immune T cells change how tau protein causes brain damage in people with Alzheimer's disease and related tau disorders.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11299000 on NIH RePORTER |
What this research studies
This project uses mouse models that develop tau buildup and that carry human APOE genes to mimic features of Alzheimer's and primary tauopathies. Scientists compare immune activity in brains with tau versus amyloid problems and study how T cells and brain immune cells (microglia) interact with tau to cause neuron loss. They pay special attention to the APOE4 gene because it appears to make tau-linked damage worse. The work aims to identify immune mechanisms that could be targeted to slow or prevent tau-driven brain decline.
Who could benefit from this research
Good fit: People with Alzheimer's disease or other tau-related dementias, especially those known to carry the APOE ε4 gene, would be the most likely candidates to benefit from findings of this work.
Not a fit: Individuals whose cognitive symptoms are caused primarily by non-tau conditions (for example, pure vascular dementia or other non-tau disorders) may be less likely to benefit.
Why it matters
Potential benefit: If successful, this research could point to new immune-based treatments to slow or prevent tau-related neurodegeneration in Alzheimer's and related dementias.
How similar studies have performed: Prior animal studies have shown that microglia and APOE4 influence tau damage, but the specific role of adaptive immune T cells in tau-driven neurodegeneration is less well understood and is relatively novel.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Holtzman, David M. — Washington University
- Study coordinator: Holtzman, David M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.